aloe emodin has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, ZM; Guo, J; Hang, PZ; Hu, J; Liu, KY; Su, ZL; Sun, HQ; Zheng, YY | 1 |
| An, R; Du, Z; He, F; Ji, H; Liu, Y | 1 |
2 other study(ies) available for aloe emodin and Hyperlipemia
| Article | Year |
|---|---|
Aloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats.
Topics: Animals; Anthraquinones; Anticholesteremic Agents; Diet, High-Fat; Hep G2 Cells; Humans; Hyperlipidemias; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; PCSK9 Inhibitors; Rats, Wistar; Receptors, LDL; Signal Transduction; Sterol Regulatory Element Binding Proteins | 2020 |
LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Topics: Animals; Anthraquinones; Biomarkers; Chromatography, High Pressure Liquid; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2018 |